1. Home
  2. FULC vs CCRN Comparison

FULC vs CCRN Comparison

Compare FULC & CCRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FULC
  • CCRN
  • Stock Information
  • Founded
  • FULC 2015
  • CCRN 1986
  • Country
  • FULC United States
  • CCRN United States
  • Employees
  • FULC N/A
  • CCRN N/A
  • Industry
  • FULC Biotechnology: Pharmaceutical Preparations
  • CCRN Professional Services
  • Sector
  • FULC Health Care
  • CCRN Consumer Discretionary
  • Exchange
  • FULC Nasdaq
  • CCRN Nasdaq
  • Market Cap
  • FULC 469.0M
  • CCRN 447.2M
  • IPO Year
  • FULC 2019
  • CCRN N/A
  • Fundamental
  • Price
  • FULC $7.87
  • CCRN $13.06
  • Analyst Decision
  • FULC Buy
  • CCRN Hold
  • Analyst Count
  • FULC 7
  • CCRN 5
  • Target Price
  • FULC $10.43
  • CCRN $17.93
  • AVG Volume (30 Days)
  • FULC 618.0K
  • CCRN 282.9K
  • Earning Date
  • FULC 10-29-2025
  • CCRN 11-05-2025
  • Dividend Yield
  • FULC N/A
  • CCRN N/A
  • EPS Growth
  • FULC N/A
  • CCRN N/A
  • EPS
  • FULC N/A
  • CCRN N/A
  • Revenue
  • FULC N/A
  • CCRN $1,192,539,000.00
  • Revenue This Year
  • FULC N/A
  • CCRN N/A
  • Revenue Next Year
  • FULC N/A
  • CCRN N/A
  • P/E Ratio
  • FULC N/A
  • CCRN N/A
  • Revenue Growth
  • FULC 2752.05
  • CCRN N/A
  • 52 Week Low
  • FULC $2.32
  • CCRN $9.58
  • 52 Week High
  • FULC $10.11
  • CCRN $18.33
  • Technical
  • Relative Strength Index (RSI)
  • FULC 40.58
  • CCRN 53.88
  • Support Level
  • FULC $8.42
  • CCRN $11.95
  • Resistance Level
  • FULC $9.47
  • CCRN $12.44
  • Average True Range (ATR)
  • FULC 0.80
  • CCRN 0.50
  • MACD
  • FULC -0.21
  • CCRN 0.01
  • Stochastic Oscillator
  • FULC 7.11
  • CCRN 76.36

About FULC Fulcrum Therapeutics Inc.

Fulcrum Therapeutics Inc is a clinical-stage biopharmaceutical company. The company's programs in clinical development are losmapimod, a small molecule for the treatment of facioscapulohumeral muscular dystrophy (FSHD) and FTX-6058, a small molecule designed to increase expression of fetal hemoglobin for the treatment of sickle cell disease and other hemoglobinopathies, including beta-thalassemia.

About CCRN Cross Country Healthcare Inc. $0.0001 Par Value

Cross Country Healthcare Inc is a provider of total talent management services, including strategic workforce solutions, contingent staffing, permanent placement and consultative services for healthcare customers. The company operates in two business segments: the nurse and allied staffing segment, which generates a vast majority of revenue, offers temporary and permanent placements of travel and local nurses and allied professionals, and other outsourcing services.: the Physician Staffing segment provides licensed practitioners across a broad array of specialties, as well as certified registered nurse anesthetists (CRNAs), nurse practitioners (NPs), and physician assistants (PAs) on temporary assignments. The company earns majority of its revenue from the United States.

Share on Social Networks: